Karen Kelly
Hematology & Oncology · Sacramento, CANPI 1477651222
Payments from drug & device makers
Across 455 payments — averaging $5179.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1M
- EMD Serono, Inc.$399K
- Genentech, Inc.$284K
- E.r. Squibb & Sons, L.L.C.$217K
- Novartis$105K
- Takeda Pharmaceuticals U.S.A., Inc.$61K
- plus $246K from 18 others
Across 4 payments — averaging $1449.57 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bristol Myers Squibb$4K
- Novartis$1K
- Regeneron$675
What the payments were for
- Royalty or licence$4,8103%
- Consulting fees$126,26386%
- Speaking & faculty fees$6300%
- Travel & lodging$13,9859%
- Food & beverage$1,9521%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 90 | $1,043,354 |
| EMD Serono, Inc. | 197 | $399,146 |
| Genentech, Inc. | 35 | $284,017 |
| E.r. Squibb & Sons, L.L.C. | 14 | $217,059 |
| Novartis | 10 | $105,461 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $61,311 |
| Regeneron | 20 | $58,252 |
| Amgen | 15 | $58,022 |
| Eli Lilly | 14 | $46,778 |
| AstraZeneca | 15 | $29,704 |
| Astrazeneca UK Limited | 7 | $10,551 |
| Sanofi | 3 | $8,045 |
| Genentech USA, Inc. | 5 | $6,656 |
| Merck | 8 | $5,801 |
| Janssen Scientific Affairs, LLC | 4 | $4,040 |
| Bard Peripheral Vascular, Inc. | 3 | $3,595 |
| Seagen Inc. | 1 | $3,400 |
| Merck Kgaa | 1 | $3,000 |
| Regeneron Healthcare Solutions, Inc. | 2 | $2,761 |
| Daiichi Sankyo Inc. | 2 | $2,368 |
| Bristol Myers Squibb | 1 | $2,223 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $1,215 |
| Jazz Pharmaceuticals Inc. | 1 | $41 |
| Nalu Medical, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,356,815 in reported general payments places this provider in the 90th percentile of 1,363 hematology & oncology providers in California.
Other hematology & oncology in Sacramento
- Joseph TuscanoSacramento$20.4M
- Jonathan RiessSacramento$9.8M
- Brian JonasSacramento$7.3M
- Alain AlgaziSan Francisco$119.2M
- David BerzLos Angeles$43.3M
- Jonathan GoldmanSanta Monica$35.7M
- Omid HamidSanta Monica$23.7M
- Nicholas McAndrewLos Angeles$22.9M
- Aditya BardiaSanta Monica$22.1M
- Zev WainbergSanta Monica$19.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.